- Feb 24
- 5 min
Transcend Therapeutics, a mental health-focused biotechnology company, closes on $40 million
. While various psychedelics have demonstrated promise for the treatment of PTSD, Transcend focuses on a psychoactive compound that may...
- Jul 5, 2022
- 2 min
Mindset Pharma develops an intranasal platform for psychedelic medicines
Mindset Pharma is focused on creating optimized and patentable next-generation psychedelic medicines to treat neurological disorders.
- Aug 9, 2021
- 2 min
Core One Labs moves forward with its clinical development for its psychedelic formulations
These studies will further enhance the Company’s knowledge supporting the use of psychedelics as strong candidates in the treatment ...
- Jun 12, 2021
- 3 min
MYND Life Sciences files patent applications for psilocybin-based drugs for depression
Mynd's process utilizes specific psilocybin analogues that have the ability to positively impact patients with neuropsychiatric disorders.
- Feb 28, 2021
- 1 min
MindMed Closes Acquisition of HealthMode, a Leading Machine Learning Digital Medicine Company
Acquisition will help build a full stack digital mental health platform for psychedelic medicines; Ex-Pfizer Digital Medicine Executive...